Mid-to-Late Life Healthy Lifestyle Modifies Genetic Risk for Longitudinal Cognitive Aging among Asymptomatic Individuals
Xu, Y.; Sun, Z.; Jonaitis, E. M.; Deming, Y.; Lu, Q.; Johnson, S. C.; Engelman, C. D.
Show abstract
IMPORTANCEGenetic and lifestyle factors contribute to an individuals risk of developing Alzheimers disease. However, it is unknown whether and how adherence to healthy lifestyles can mitigate the genetic risk of Alzheimers. OBJECTIVEThe aim of this study is to investigate whether adherence to healthy lifestyles can modify the impact of genetic predisposition to Alzheimers disease on later-life cognitive decline. DESIGN, SETTING, AND PARTICIPANTSThis prospective cohort study included 891 adults of European ancestry, aged 40 to 65, who were without dementia and had complete healthy-lifestyle and cognition data during the follow-up. Participants joined the Wisconsin Registry for Alzheimers Prevention (WRAP) beginning in 2001. We conducted replication analyses using a subsample with similar baseline age range from the Health and Retirement Study (HRS). EXPOSURESWe assessed participants exposures using a continuous non-APOE polygenic risk score for Alzheimers, a binary indicator for APOE-{varepsilon}4 carrier status, and a weighted healthy-lifestyle score, including factors such as no current smoking, regular physical activity, healthy diet, light to moderate alcohol consumption, and frequent cognitive activities. MAIN OUTCOMES AND MEASURESWe z-standardized cognitive scores for global (Preclinical Alzheimers Cognitive Composite score 3 - PACC3) and domain-specific assessments (delayed recall and immediate learning). RESULTSWe followed 891 individuals for up to 10 years (mean [SD] baseline age, 58 [6] years, 31% male, 38% APOE-{varepsilon}4 carriers). After false discovery rate (FDR) correction, we found statistically significant PRS x lifestyle x age interactions on preclinical cognitive decline but the evidence is stronger among APOE-{varepsilon}4 carriers. Among APOE-{varepsilon}4 carriers, PRS-related differences in overall and memory-related domains between people scoring 0-1 and 4-5 regarding healthy lifestyles became evident around age 67 after FDR correction. These findings were robust across several sensitivity analyses and were replicated in the population-based HRS. CONCLUSIONA favorable lifestyle can mitigate the genetic risk associated with current known non-APOE genetic variants for longitudinal cognitive decline, and these protective effects are particularly pronounced among APOE-{varepsilon}4 carriers. KEY POINTSQuestion: Can a healthy lifestyle modify genetic susceptibility to Alzheimers disease and its impact on cognitive decline? Findings: In two longitudinal studies, we found that adhering to a healthy lifestyle can reduce the adverse genetic effects of known non-APOE variants, especially in APOE-{varepsilon}4 carriers. Specifically, APOE-{varepsilon}4 carriers with <2 healthy lifestyle factors had significantly higher genetic risk caused by currently known genetic variants compared to those with two or more. Meaning: A healthy lifestyle can mitigate genetic risks from non-APOE variants, especially among APOE-{varepsilon}4 carriers. Future research should include biomarker analysis to uncover the underlying biological mechanisms.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Individual bioenergetic capacity as a potential source of resilience to Alzheimer’s disease 96%
- Plasma biomarkers of Alzheimer’s disease predict cognitive decline and could improve clinical trials in the cognitively unimpaired elderly 94%
- Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease 94%
Similar papers in this journal
- DNA methylation age acceleration is associated with incident cognitive impairment in the Health and Retirement Study 94%
- Frequency of Variants in Mendelian Alzheimer’s Disease Genes within the Alzheimer’s Disease Sequencing Project (ADSP) 93%
- Exploring the genetic heterogeneity of Alzheimer’s disease: Evidence for genetic subtypes 93%
Similar papers in this journal
- Adherence to Life’s Essential 8 is associated with delayed white matter aging 95%
- Prediction of brain age using structural magnetic resonance imaging: A comparison of clinical validity of publicly available software packages 93%
- The ratio of plasma pTau181 and pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosis 92%
Similar papers in this journal
- Manifestations of genetic risk for Alzheimer's Disease in the blood: a cross-sectional multi-omic analysis in healthy adults aged 18-90+ 97%
- Little genomic support for cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers 95%
- Peripheral inflammation is associated with structural brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer's disease 94%